ORAL FORMULATIONS CONTAINING HYALURONIC ACID FOR SUSTAINED DRUG RELEASE

摘要

The present invention discloses a tablet or a capsule for oral administration comprising 0.5 - 0 % (w/w) hyaluronic acid or a salt thereof, an active pharmaceutical ingredient (API), and a coating.